Subsequent investigations have revealed that, in comparison to monospecific CAR T-cells, a bispecific TanCAR configuration incorporating a “Her-2-binding single-chain variable fragment (scFv)/mutated IL-13” heterodimer has demonstrated enhanced survival rates in GBM models. The gene discussed is IL13; the disease is glioblastoma.